India to Kenya: Ceftazidime Export Trade Route

The India to Kenya Ceftazidime corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $255.4K USD. The route is dominated by THEON PHARMACEUTICALS LIMITED, which alone accounts for roughly 35% of all export value, reflecting the consolidated nature of India's ceftazidime manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $8.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with ceftazidime's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 20.9%, placing it at rank #11 among India's top ceftazidime export destinations globally.

On the import side, key buyers of Indian ceftazidime in Kenya include SYNER-MED PHARMACEUTICALS(KENYA), PHARMAKEN LTD, SYNER-MED PHARMACEUTICALS KENYA and 12 others. SYNER-MED PHARMACEUTICALS(KENYA) is the single largest importer with 7 shipments valued at $62.0K USD.

India's ceftazidime exports to Kenya are driven primarily by a handful of large-scale manufacturers. THEON PHARMACEUTICALS LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — THEON PHARMACEUTICALS LIMITED, AVIAN INTERNATIONAL, THEON PHARMACEUTICALS LIMITED — together account for 70% of total trade value on this route. The average shipment value of $8.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as syner-zed 1 g ceftazidime for injection and (ceftazidime for injection usp 1000 mg)synerzed 1 g batch no.eczdm23007 mfg.dt.dec-2023 exp.dt.nov-2026nos, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SYNER-MED PHARMACEUTICALS(KENYA) is the largest importer with 7 shipments worth $62.0K USD — representing 24% of all ceftazidime imports from India on this route. A total of 15 buyers are active on this corridor.